Preventive and therapeutic approaches to viral agents of bioterrorism

被引:10
作者
Bronze, MS [1 ]
Greenfield, RA
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Div Infect Dis, Oklahoma City, OK USA
[2] Vet Adm Med Ctr, Oklahoma City, OK 73104 USA
关键词
D O I
10.1016/S1359-6446(03)02778-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Certain viruses, such as those that cause smallpox and hemorrhagic fevers, have been identified as possible bioterrorism agents by the Centers for Disease Control and Prevention. They have been designated as potential threats because large quantities can be propagated in cell culture, they are transmissible as aerosols and, for the most part, there are only limited vaccine and pharmaceutical strategies for either prevention or treatment of established infection. An additional concern is the potential to genetically modify these agents to enhance virulence or promote resistance to vaccines or identified antivirals. Although the major impact of these agents is human illness, the release of zoonotic agents, such as the Nipah virus, would have consequences for both humans and animals because infected and noninfected animals might need to be sacrificed to control the spread of infection. Continued research is necessary to develop effective strategies to limit the impact of these biological threats.
引用
收藏
页码:740 / 745
页数:6
相关论文
共 60 条
[1]   Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections [J].
Baker, R ;
Bray, M ;
Huggins, JW .
ANTIVIRAL RESEARCH, 2003, 57 (1-2) :13-23
[2]  
BAUER DJ, 1962, B WORLD HEALTH ORGAN, V26, P727
[3]   The new cell culture smallpox vaccine should be offered to the general population [J].
Bicknell, W ;
James, K .
REVIEWS IN MEDICAL VIROLOGY, 2003, 13 (01) :5-15
[4]   Hemorrhagic fever viruses as biological weapons - Medical and public health management [J].
Borio, L ;
Inglesby, T ;
Peters, CJ ;
Schmaljohn, AL ;
Hughes, JM ;
Jahrling, PB ;
Ksiazek, T ;
Johnson, KM ;
Meyerhoff, A ;
O'Toole, T ;
Ascher, MS ;
Bartlett, J ;
Breman, JG ;
Eitzen, EM ;
Hamburg, M ;
Hauer, J ;
Henderson, A ;
Johnson, RT ;
Kwik, G ;
Layton, M ;
Lillibridge, S ;
Nabel, GJ ;
Osterholm, MT ;
Perl, TM ;
Russell, P ;
Tonat, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (18) :2391-2405
[5]   A model for a smallpox-vaccination policy [J].
Bozzette, SA ;
Boer, R ;
Bhatnagar, V ;
Brower, JL ;
Keeler, EB ;
Morton, SC ;
Stoto, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (05) :416-425
[6]   Defense against filoviruses used as biological weapons [J].
Bray, M .
ANTIVIRAL RESEARCH, 2003, 57 (1-2) :53-60
[7]   Progressive vaccinia [J].
Bray, M ;
Wright, ME .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (06) :766-774
[8]   Treatment of aerosolized cowpox virus infection in mice with aerosolized cidofovir [J].
Bray, M ;
Martinez, M ;
Kefauver, D ;
West, M ;
Roy, C .
ANTIVIRAL RESEARCH, 2002, 54 (03) :129-142
[9]   Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor [J].
Bray, M ;
Driscoll, J ;
Huggins, JW .
ANTIVIRAL RESEARCH, 2000, 45 (02) :135-147
[10]   Preventing the return of smallpox [J].
Breman, JG ;
Arita, I ;
Fenner, F .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (05) :463-466